These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12142589)

  • 1. Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction.
    Talmor M; Hoffman LA; LaTrenta GS
    Ann Plast Surg; 2002 Jul; 49(1):11-7; discussion 117-8. PubMed ID: 12142589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction.
    Hodgkinson DJ
    Ann Plast Surg; 2003 Mar; 50(3):328. PubMed ID: 12800915
    [No Abstract]   [Full Text] [Related]  

  • 3. Facial atrophy in HIV-related fat redistribution syndrome: a plastic surgical perspective on treatment options and a look to the future.
    Abood A; Ong J; Withey S; Johnson M; Butler P
    Int J STD AIDS; 2006 Apr; 17(4):217-20. PubMed ID: 16595041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
    Mori A; Lo Russo G; Agostini T; Pattarino J; Vichi F; Dini M
    J Plast Reconstr Aesthet Surg; 2006; 59(11):1209-16. PubMed ID: 17046631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary surgical management of HIV-associated facial lipoatrophy.
    Funk E; Bressler FJ; Brissett AE
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of custom-designed midfacial and submalar implants in the treatment of facial wasting syndrome.
    Binder WJ; Bloom DC
    Arch Facial Plast Surg; 2004; 6(6):394-7. PubMed ID: 15545534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A facial marker in facial wasting rehabilitation.
    Rauso R; Tartaro G; Freda N; Rusciani A; Curinga G
    J Drugs Dermatol; 2012 Feb; 11(2):202-8. PubMed ID: 22270203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of facial lipoatrophy].
    Caye N; Le Fourn B; Pannier M
    Ann Chir Plast Esthet; 2003 Feb; 48(1):2-12. PubMed ID: 12657329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of facial lipoatrophy via autologous fat transfer.
    Cohen G; Treherne A
    J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gluteal Augmentation With Intramuscular Implants in Patients With Human Immunodeficiency Virus With Lipoatrophy Related to the Use of Antiretroviral Therapy.
    Andrade GA; Coltro PS; Barros ME; Müller Neto BF; Lima RV; Farina JA
    Ann Plast Surg; 2017 Nov; 79(5):426-429. PubMed ID: 28604545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiretroviral treatments-related lipodystrophy syndrome: clinico-pathological findings].
    Lassalle S; Cervera P; Hofman V; Mari M; Dellamonica P; Hofman P
    Ann Pathol; 2005 Sep; 25(4):309-17. PubMed ID: 16327657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
    Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
    Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.
    Piloya T; Bakeera-Kitaka S; Kekitiinwa A; Kamya MR
    J Int AIDS Soc; 2012 Jul; 15(2):17427. PubMed ID: 22814353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and Successful Technique for the Management of Parry-Romberg Syndrome's Soft Tissue Atrophy.
    Ortega VG; Sastoque D
    J Craniofac Surg; 2015 Sep; 26(6):e507-10. PubMed ID: 26335318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industrial-grade silicone injections causing intermittent bilateral malar swelling: review of safety and efficacy of techniques and products available.
    Seward AC; Meara DJ
    J Oral Maxillofac Surg; 2013 Jul; 71(7):1245-8. PubMed ID: 23522770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to the human immunodeficiency virus-infected patient with lipodystrophy.
    Brown TT
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2937-45. PubMed ID: 18685115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of human immunodeficiency virus-associated lipodystrophy with dermafat graft transfer to the malar area.
    Strauch B; Baum T; Robbins N
    Plast Reconstr Surg; 2004 Jan; 113(1):363-70; discussion 371-2. PubMed ID: 14707661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
    Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
    AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
    HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-associated facial lipoatrophy--review of current therapy options.
    Bechara FG; Sand M; Potthoff A; Altmeyer P; Brockmeyer NH;
    Eur J Med Res; 2008 Mar; 13(3):93-9. PubMed ID: 18499554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.